Oral cancer progression and c-erbB-2/neu proto-oncogene expression

Banoczy, 1976, Occurrence of epithelial dysplasia in oral leukoplakia, Oral Surg., 42, 766, 10.1016/0030-4220(76)90099-2 Bargmann, 1986, Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185, Cell, 45, 649, 10.1016/0092-8674(86)90779-8 D'Emilia, 1989, Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon, Oncogene, 4, 1233 Fukushige, 1986, Localization of a novel v-erbB-related gene, c-erbB-2, on chromosome 17 and its amplification in a gastric cancer cell line, Mol. Cell Biol., 6, 955, 10.1128/MCB.6.3.955 Hsu, 1982, Discovery of a high affinity of phaseolus vulgaris agglutinin (PHA) with gastrosecreting cells, Am. J. Clin. Pathol., 77, 396, 10.1093/ajcp/77.4.396 Hsu, 1981, Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29, 577, 10.1177/29.4.6166661 Hung, 1986, Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles, 83, 261 King, 1985, Amplification of a novel v-erbB-related gene in a human mammary carcinoma, Science, 229, 974, 10.1126/science.2992089 Kraus, 1987, Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms, EMBO J., 6, 605, 10.1002/j.1460-2075.1987.tb04797.x Lacroix, 1989, Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases, Oncogene, 4, 145 Schantz, 1990, Experimental Head and Neck Oncology, Curr. Opin. Oncol., 2, 546, 10.1097/00001622-199006000-00018 Schneider, 1989, Differential expression of c-erbB-2 gene in human small cell lung cancer, Cancer Res., 49, 4968 Schubert, 1974, Clonal cell lines from the rat central nervous system, Nature, 249, 224, 10.1038/249224a0 Semba, 1985, A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor receptor gene and is amplified in human salivary gland adenocarcinoma, 82, 6497 Shi, 1992, Overexpression of the c-erbB-2/neuencoded p185 protein in primary lung cancer, Mol. Carcinogen., 10.1002/mc.2940050308 Slamon, 1987, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, 240, 177, 10.1126/science.3798106 Slamon, 1989, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, 244, 707, 10.1126/science.2470152 Snedecor, 1980, 206 Stern, 1988, Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo, Mol. Cell Biol., 8, 3969, 10.1128/MCB.8.9.3969 Tauchi, 1989, Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions, with special reference to their prognostic significance in carcinoma, Virchows Arch., 416, 65, 10.1007/BF01606471 Walker, 1989, An immunohistochemical and insitu hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinoma, J. Pathol., 158, 97, 10.1002/path.1711580204 WHO, 1978, WHO Collaborating Center for oral precancerous lesions: definition of leukoplakia and related lesions: an aid to studies on oral precancer, Oral Surg., 46, 518, 10.1016/0030-4220(78)90383-3 Wong, 1988, Transforming growth factor alpha in chemically transformed oral keratinocytes, Cancer Res., 48, 3130 Zhang, 1989, Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract, Oncogene, 4, 985